Cargando…
MicroRNA-129 Inhibits Glioma Cell Growth by Targeting CDK4, CDK6, and MDM2
Glioblastoma is the most common malignant primary brain tumor among adults and one of the most lethal cancers. It is characterized by the deregulation of signaling pathways involving proliferation, growth, survival, and other factors. MicroRNAs (miRNAs) play a role in the regulation of genes by affe...
Autores principales: | Moradimotlagh, Atieh, Arefian, Ehsan, Rezazadeh Valojerdi, Rezvan, Ghaemi, Shokoofeh, Jamshidi Adegani, Fatemeh, Soleimani, Masoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965505/ https://www.ncbi.nlm.nih.gov/pubmed/31954330 http://dx.doi.org/10.1016/j.omtn.2019.11.033 |
Ejemplares similares
-
Differentiation MicroRNAs Affect Stemness Status of USSCs
por: Jamshidi Adegani, F, et al.
Publicado: (2011) -
The miR-142 Suppresses U-87 Glioblastoma Cell Growth by Targeting EGFR Oncogenic Signaling Pathway
por: Gheidari, Fatemeh, et al.
Publicado: (2021) -
Comparative study of the cytotoxicity, apoptotic, and epigenetic effects of Boswellic acid derivatives on breast cancer
por: Jamshidi-adegani, Fatemeh, et al.
Publicado: (2022) -
Combined targeting of MDM2 and CDK4 is synergistic in dedifferentiated liposarcomas
por: Laroche-Clary, Audrey, et al.
Publicado: (2017) -
CDK4 inhibition diminishes p53 activation by MDM2 antagonists
por: Sriraman, Anusha, et al.
Publicado: (2018)